Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

NCT06344156 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Adjuvant Therapy

Interventions

DRUG: Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy

Sponsor

Sichuan University